Roche

Switzerland
Breíl, Grisons, Switzerland, 4070

Company profile

Roche company profile

Roche is a pharmaceutical and diagnostics company that focused on improving people’s lives. Roche is the owner of F. Hoffmann-La Roche Ltd. Roche is a provider of in-vitro diagnostics and drugs for cancer and transplantation. It specializes in medicines for oncology, virology, inflammation, metabolism, CNS, clinical chemistry, immunology, urinalysis, blood screening, genetics, infectious diseases, and microbiology. F. Hoffmann-La Roche Ltd. serves hospitals, research labs, private medical labs, practicing physicians, and patients. Its products include cancer treatments, such as Avastin, Herceptin, and MabThera which are also effective in the treatment of rheumatoid arthritis, anemia, and osteoporosis. F. Hoffmann-La Roche Ltd. also conducts research and development as well as production related to molecular diagnostic reagents, test systems, and test kits. In addition, it provides automated instruments, software, consumables, and IT solutions used in in-vitro diagnostics and research.

Business identity

Phone number
+41 61 688 1111
Operating status
Active
Company type
For Profit
Employee range
10,001+ employees
Revenue range
$10M+
Founded
1896-01-15

Headquarters

Postal code
4070
Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
4
Total equity funding
$7.8B
Last funding
Post IPO Equity / $5B / 2021-08-04
Last equity funding
Post IPO Equity / $5B
Investors
3
Lead investors
3
Founders
1
Articles
4,617
Exited on
2020-12-07

Founders and investors

Founders

Fritz Hoffman-La Roche

Lead investors

NovartisSCALE AISoftBank

Investors

NovartisSCALE AISoftBank